Trial Profile
A Phase II, Multi-center, Randomized, Double-blind Study Comparing the Safety and Efficacy of Two Doses of BC-3781 Versus Vancomycin in Patients With Acute Bacterial Skin and Skin Structure Infection
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Oct 2020
Price :
$35
*
At a glance
- Drugs Lefamulin (Primary) ; Vancomycin
- Indications Gram-positive infections; Skin and soft tissue infections
- Focus Therapeutic Use
- Sponsors Nabriva Therapeutics
- 01 Apr 2019 Results assessing the pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing in four studies (NCT01119105, NCT02557789, EudraCT2012-004404-35 and EudraCT2012-000025-50) published in the Journal of Antimicrobial Chemotherapy
- 20 Sep 2011 Results presented at the 51st Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 12 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.